Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease - Wikidata - awgldk - TriplyDB

Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease

Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease

http://www.wikidata.org/entity/Q28190165

about

Adenosine receptors as therapeutic targets Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease.Recent developments in adenosine receptor ligands and their potential as novel drugs Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease.Rescuing the Corticostriatal Synaptic Disconnection in the R6/2 Mouse Model of Huntington's Disease: Exercise, Adenosine Receptors and Ampakines Xanthines as adenosine receptor antagonists.International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update Pathophysiological roles for purines: adenosine, caffeine and urate.Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.The role of adenosine in Alzheimer's disease Effectiveness and tolerability of istradefylline for the treatment of restless legs syndrome: an exploratory study in five female patients.Design and evaluation of xanthine based adenosine receptor antagonists: potential hypoxia targeted immunotherapies.Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases.Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade A novel diketopiperazine improves functional recovery given after the onset of 6-OHDA-induced motor deficit in rats Adenosine A(2A) Receptor Binding Profile of Two Antagonists, ST1535 and KW6002: Consideration on the Presence of Atypical Adenosine A(2A) Binding Sites.Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia.Antiparkinsonian Efficacy of Guanosine in Rodent Models of Movement Disorder.

P2860

Q24632095-0B1B0427-C6A0-4F9E-B18A-D2188B4C66A7 Q24815335-71B8B466-FED2-40C3-AEBA-D1BB56AA5FB0 Q27687253-4992306B-2A90-4157-9C45-8FAA2079177F Q30484170-8A6A1D78-FD7C-4C6E-8792-10DABD8A84B4 Q33705003-DC43BA5B-5E7C-4A2B-94CC-7DD65036C93C Q34139398-55C262FA-2989-44C9-A4D0-54667AC42658 Q34701303-4C5DEA54-4394-4FB0-B6BD-BED635B808C4 Q35008049-5D7C871A-2D52-41F6-B868-B43D86FA124F Q35489240-9EFE34CE-6998-4190-A164-FEE60E34A7B1 Q37402673-6BD69833-185F-4582-824C-44139C71C368 Q37672812-433548D6-41BC-4AE2-A0CE-2BBD77C25C38 Q39078481-C89B3DFD-2F49-46DB-B3BD-63F98D395886 Q39157059-F3176A9F-1E5B-4232-9947-6A1ACA68738B Q40722338-1BC927CC-0D3F-41CE-A60D-4D142C53BB7C Q41428650-D5695A20-043E-4909-A22E-6058F9ED578C Q41849265-761E9BFD-83AA-48B0-B871-8C98861EF28F Q41899842-F6322F24-6041-4BB3-9DB1-276D07994B8F Q42372900-23786A57-679C-47D3-8A8C-20BF88C2ED12

P2860

Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease

http://www.wikidata.org/entity/Q28190165

description

2003 nî lūn-bûn

@nan

2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Progress in pursuit of therape ...... herapy for Parkinson's disease

@ast

Progress in pursuit of therape ...... herapy for Parkinson's disease

@en

Progress in pursuit of therape ...... herapy for Parkinson's disease

@nl

type

label

Progress in pursuit of therape ...... herapy for Parkinson's disease

@ast

Progress in pursuit of therape ...... herapy for Parkinson's disease

@en

Progress in pursuit of therape ...... herapy for Parkinson's disease

@nl

prefLabel

Progress in pursuit of therape ...... herapy for Parkinson's disease

@ast

Progress in pursuit of therape ...... herapy for Parkinson's disease

@en

Progress in pursuit of therape ...... herapy for Parkinson's disease

@nl

P1433

Q28190165-9477793E-8E9E-4F84-ABDA-BA29C2F87341

P1476

Q28190165-247C503F-0ECE-4647-8F7C-3BFAEA2BCC1A

P2093

Q28190165-03E3A9D5-3BAD-4B8A-BAB5-1217D197A35D

Q28190165-07643EBD-2DDC-4A59-934E-B39725BECB71

Q28190165-1C78E50E-1818-4CCF-ADBB-2F61471D81C9

Q28190165-210EBDB4-5633-414D-BD1A-89524ED4B1B6

Q28190165-2D4C8855-1513-4F3C-94B7-2EDFA021B00D

Q28190165-3C2DD666-189B-481A-8CA1-2697B0E67B01

Q28190165-3DE8DF9F-A3F9-453D-AEE7-B144C7566BFA

Q28190165-4A06DF37-3F4B-4553-BB78-53DF4E121829

Q28190165-4AC06071-220F-4BE5-9E9D-4E10746D5963

Q28190165-5209CF4A-9500-4F9E-8772-DAAE91F04096

P304

Q28190165-26B121E1-4909-44AB-89D8-C50AB52B0A28

P31

Q28190165-033e1182-17a2-463a-9d76-a923b99dfa84

Q28190165-9D1A2F0A-24B4-4773-9447-E0D534F6DE73

P407

Q28190165-9BBFB2F2-E168-46F1-89A5-2EF69305D960

P433

Q28190165-0647E124-ADB0-4F3A-B5A0-95764F89F443

P478

Q28190165-002BE24C-7539-4A61-8A64-39BAF513FEEC

P577

Q28190165-B95615E3-1A72-4D80-93D9-D0DA7D385E33

P698

Q28190165-B2B9E84E-396C-4CDC-A12D-1989E04C49FA

P921

Q28190165-5B29DB52-0E57-44D2-BC9F-3476F7192591

P1433

P1476

Progress in pursuit of therape ...... herapy for Parkinson's disease

@en

P2093

A Ishii

http://www.w3.org/2001/XMLSchema#string

A Mori

http://www.w3.org/2001/XMLSchema#string

E Borrelli

http://www.w3.org/2001/XMLSchema#string

F Suzuki

http://www.w3.org/2001/XMLSchema#string

H Nonaka

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kase

http://www.w3.org/2001/XMLSchema#string

J Nakamura

http://www.w3.org/2001/XMLSchema#string

J Shimada

http://www.w3.org/2001/XMLSchema#string

K Ikeda

http://www.w3.org/2001/XMLSchema#string

K Koga

http://www.w3.org/2001/XMLSchema#string

P304

S97-100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

11 Suppl 6

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P577

2003-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14663020

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease